Safety and Efficacy of Orelabrutinib O in Combination With Thiotepa T in Refractory and Relapsed Primary CNS Lymphoma A Single-arm, Multicenter Phase Ib/II Study OT
Latest Information Update: 06 Jun 2024
At a glance
- Drugs Orelabrutinib (Primary) ; Thiotepa (Primary) ; Sintilimab
- Indications CNS cancer; Lymphoma
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2021 New trial record